Octopus Energy Generation, Octopus Energy’s renewable energy generation arm, has acquired a 10% stake in the East Anglia One ...
Spark Therapeutics Inc. has presented a proprietary adeno-associated viral (AAV) vector expressing an artificial miRNA targeting human α-synuclein (α-Syn) mRNA. Accumulation of misfolded and insoluble ...
Variant SAS and the Rare Ocular Diseases Center at the University of Campania Luigi Vanvitelli (UCLV) have received positive feedback from the EMA for VAR-002, a recombinant AAV vector gene therapy ...
During our journey around campus, we visited the USU Student Media office, where Sage happily greeted a group of students, ...
Spring may have only just started showing signs of life in northern parts of the country, but tick season has already begun.
The suggested readings in this installment of the "Leaders Are Readers" series offer insights about leading teams, acts of ...
Rescue workers saved a 63-year-old woman from the rubble of a building in Myanmar's capital Tuesday, but hope was fading of finding man ...
Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...
D Molecular Therapeutics, Inc.’s FDMT share price has dipped by 10.90%, which has investors questioning if this is right time to buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results